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Objective: To assess the value of intraoperative graft flow and resistance measurements and a graft surveillance program to
predict at-risk infra-inguinal bypass grafts.
Methods: Four hundred sixty-eight infra-inguinal bypass procedures performed between 1995-2006 underwent intraop-
erative measurement of graft flow and resistance using a Scimed OpDop. These data were correlated with graft outcome
at six weeks. Two hundred fifty-four (73%) grafts were entered into a graft surveillance program and the effect of this on
primary-assisted graft patency was assessed.
Results:Overall primary and primary-assisted graft patency was 81% and 83% at six weeks and 42% and 64% at three years.
Grafts failing by six weeks had significantly lower flow (130.5 mL/min vs. 150.5 mL/min, P  .009) and higher
resistance (0.67 peripheral resistance units (PRU) vs. 0.57 PRU, P  .004) than those remaining patent. However,
OpDop measured flow and resistance was a poor predictor of graft failure in individual cases (area under ROC curve,
0.57). While there was no statistical difference in primary 18-month patency rates between grafts undergoing surveillance
and those undergoing clinical follow up (55% vs. 76%, P  .133), primary-assisted 18-month patency rates were
significantly higher in the surveillance group (83% vs. 77%, P  .042).
Conclusion: Intraoperative measurements of graft flow and resistance do not predict graft outcome at six weeks. However,
surveillance does identify at-risk grafts and improves mid-term primary-assisted patency. (J Vasc Surg 2009;49:1452-8.)Autologous vein is the conduit of choice for infra-
inguinal bypass grafts.1 Overall, the failure rate of infra-
inguinal vein grafts at one year is in the order of 20%-30%,
being greater for more distal grafts and for grafts performed
for chronic critical limb ischaemia.1 The main causes of
early failure (within days to weeks) are technical errors,
problems with the graft itself such as poor quality vein,
twisting, kinking or external compression, anatomic factors
such as poor inflow or poor run-off (ie, poor selection), and
systemic factors such as hypercoagulability or sustained
periods of systemic hypotension.2,3 Mid-term failure of
vein grafts is primarily due to myo-intimal hyperplasia
occurring at the anastamoses or in-graft stenoses, many of
which are asymptomatic.4,5 Late graft failure is primarily
the result progression of inflow or distal disease.1 Early
identification of a number of these factors may allow the
instigation of appropriate treatment resulting in improved
graft patency.6
Intraoperative assessment of grafts such as completion
angiography,7 angioscopy,8 and intraoperative Duplex9
aim to identify technical problems and detect grafts at
‘high-risk’ of early failure. On the whole, these techniques
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1452however have not proved particularly effective at reducing
early graft failure10,11 and, although intraoperative Duplex
holds the most promise, it is hampered by wide inter-
operator variability. We postulated that the SciMed OpDop
(SciMed Ltd, Bristol, United Kingdom), a device which
standardizes Doppler measured flow and resistance in com-
pleted grafts, may be more effective at predicting early graft
failure.
Duplex graft surveillance programs have been used in
many centers to identify grafts susceptible to mid-term
failure by the development of in-graft stenoses or by pro-
gression of inflow or outflow disease. Identification of
problems allows intervention with the aim of improving
graft survival. Despite their widespread use, debate still
surrounds their cost and clinical effectiveness.
The aims of this study, therefore, were to first evaluate
the effectiveness of intraoperative Doppler graft assessment
with the OpDop to predict early graft failure at six weeks,
and second to assess the effect of a graft surveillance pro-
gram on mid-term patency rates.
METHODS
Patients. A prospectively gathered comprehensive
vascular database of all 468 consecutive infra-inguinal vein
graft bypass procedures performed by three consultant
vascular surgeons (A.D.H., A.D.F., and T.C.F.S.) between
April 1995 and December 2006 was interrogated for de-
mographic, operative, and outcome data. The database
recorded demographic details, including mortality data,
details of all operative interventions, including amputa-
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clinic visits, and data on all vascular imaging performed.
Intraoperative graft assessment. Intraoperative as-
sessments of graft function were made following graft
completion and restoration of ante-grade flow in all cases.
The SciMed OpDop allows an objective assessment of graft
function to be made. After calibration for graft size and
mean arterial blood pressure, OpDop-calculated graft
blood flow and resistance was recorded before and after
intra-arterial administration of papaverine hydrochloride
(20 mg) to produce peripheral vasodilatation.12 The Doppler
probe was attached to the distal portion of the graft,
10-15cm proximal to the distal anastamosis to reduce the
error caused by turbulent flow.
Graft flow (mLs/min) and resistance (peripheral resis-
tance units [PRU]) before and after papaverine was corre-
lated with graft outcome at six weeks to assess whether
these values could predict early graft outcome.
Surveillance program. The graft surveillance pro-
gram commenced in 1999 and all infra-inguinal bypass
grafts that were clinically patent on hospital discharge after
this date were entered into the program and underwent
surveillance at six weeks and then again at three, six, nine,
12, and 18 months post-operation. Grafts remaining patent
at the end of the surveillance program were followed up
clinically, usually on an annual basis. If any intervention was
required to maintain graft patency during this period, the
surveillance clock was reset and the schedule restarted again
six weeks post-intervention. Grafts were assessed by duplex
ultrasonography (Philips ATL HDI-3000, Philips Medical
Systems, Reigate, United Kingdom) by experienced vascu-
lar technicians using either a linear 7 MHz or a curvilinear
3.5 MHz probe. Subjects identified with a significant graft
stenosis (three-fold velocity increase, equating to a 70%
stenosis13) were discussed with a Consultant vascular sur-
geon and/or Consultant vascular interventional radiologist
and underwent an urgent transfemoral angiogram and bal-
loon angioplasty of the affected segment, usually on the
next available list. Stenoses resistant to angioplasty or re-
current stenoses requiring multiple endovascular proce-
dures underwent surgical patch angioplasty.
Subjects undergoing bypass before the commencement
of the surveillance program were followed up clinically in
the outpatient setting with assessment of pulse status and
measurement of ankle: brachial pressure index (ABPI). This
follow up usually occurred at six weeks, and at six, 12, and
18 months if no problems were encountered or, more
frequently, in cases with tissue loss or postoperative com-
plications. Criteria for performing a graft duplex scan in this
group included; development of new symptoms (worsen-
ing claudication distance or rest pain); loss of peripheral
pulses or graft pulse when previously palpable; or reduction
in ABPI 0.15.
Subjects undergoing graft surveillance were compared
with the group followed up clinically to assess the effect of
surveillance on primary-assisted graft patency.
Statistical analysis. Statistical analysis was performed
using SPSS 11.0 (Statistical Package for Social Sciences Inc,Chicago, Ill). Groups were compared at baseline using
analysis of variance (ANOVA) test for continuous data and
the Chi-squared test for categorical data. In line with
published guidelines,14 we defined primary patency as graft
patency without a significant stenosis requiring interven-
tion. Primary-assisted patency was defined as graft patency
after intervention for a graft stenosis. Intraoperative Dopp-
ler measurements were compared using the Mann-Whitney
test and the predictive value of these measurements to
predict graft outcome were further assessed with receiver
operating characteristics (ROC). Kaplan-Meier plots were
used to assess patency rates over time, which were estimated
by life-table analysis and compared with the log-rank test. A
P value of less than .05 was considered statistically signifi-
cant.
RESULTS
Clinical data. The demographic and operative details
of the subjects enrolled are shown in Table I. The mean
(standard deviation [sd]) follow-up was 77.5 (101.8) weeks
with a shorter length of follow-up seen for fem-distal grafts
(52.1 (87.1) weeks, P  .002, ANOVA). Although there
was a fairly even split in the numbers of graft type, there
were significantly more femoro-above knee popliteal grafts
performed than femoro-distal grafts (P  .003, ANOVA).
Most grafts were performed for critical limb ischaemia
(CLI) (63.3%) and the overwhelming majority used re-
versed great saphenous vein (GSV) vein as the conduit
(84.2%). Subgroup analysis showed that subjects undergo-
ing femoro-distal bypass grafting were significantly older
(P .003, ANOVA) and more likely to be operated on for
CLI (P .001, Chi-squared) than subjects with a femoro-
above knee popliteal graft.
Overall, six-week primary and primary-assisted patency
rates were 81% and 83%, respectively, and 18-month pri-
mary and primary-assisted patency rates were 53% and 70%,
respectively. As expected, more proximal grafts had supe-
rior patency rates (Table I).
There was no significant difference in 30-day mortality
between the three graft groups, however one-year and
three-year mortality rates were significantly higher in sub-
jects undergoing femoro-distal grafts (P  .001, Chi-
squared). Significantly more subjects undergoing femoro-
distal grafts subsequently required a major amputation
(P  .003, Chi-squared) than in the other graft groups.
Subjects with grafts failing by six weeks had a poor out-
come, with a 33% amputation rate and 12% mortality.
OpDop measurements. Flow and resistance measure-
ments by graft indication and graft type are shown in Table II.
There was no significant difference in pre-papaverine graft
flow rates or resistance between subjects operated on for
non-critical limb ischaemia (intermittent claudication or
popliteal aneurysm) or critical limb ischaemia. However,
flow and resistance measurements were significantly more
favorable for non-critical ischaemia following the adminis-
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pre- and post-papaverine, were significantly better in
femoro-popliteal grafts compared with femoro-distal grafts
(Table II).
The details of pre- and post-papaverine OpDop mea-
sured flow and resistance and the correlation with six-week
Table I. Demographic details of subjects
All grafts
Number 468
Mean age (sd) years 71.3 (10.8)
Gender M:F 325:143
Mean follow-up (sd), weeks 77.5 (101.8)
Indication for surgery
Disabling IC 110 (24)
CLI – rest pain 131 (28)
CLI – tissue loss 165 (35)
Popliteal aneurysm 34 (7)
ALI 28 (6)
Conduit
Reversed GSV 394 (84)
In situ GSV 32 (7)
Cephalic vein 42 (9)
Clinical outcome
Six-week primary patency 81%
Six-week primary-assisted patency 83%
18-month primary patency 53%
18-month primary-assisted patency 70%
30-day mortality 20 (4)
One-year mortality 61 (13)
Three-year mortality 87 (19)
Major amputation 57 (12)
ALI, Acute limb ischaemia; CLI, critical limb ischaemia; F, female; Fem-AK
graft; Fem-distal, femoro-distal graft; GSV, great saphenous vein; IC, interm
Values are given as n (%) of patients unless stated otherwise. Figures in bol
*One way analysis of variance (ANOVA).
†Chi-squared test.
¶Log rank test.








Pre-papaverine 150.3 (70.2) 139.2 (70.2) .998
Post-papaverine 260.8 (83.4) 218.1 (96.2) <.001
Resistance (PRU)
Pre-papaverine 0.58 (0.28) 0.60 (0.27) .363
Post-papaverine 0.33 (0.21) 0.37 (0.16) .008
Graft type Femoro-popliteal Femoro-distal P
Flow (mLs/min)
Pre-papaverine 155.3 (79.7) 119.5 (57.6) <.001
Post-papaverine 255.4 (101.6) 186.9 (78.4) <.001
Resistance (PRU)
Pre-papaverine 0.54 (0.24) 0.72 (0.32) <.001
Post-papaverine 0.31 (0.13) 0.45 (0.23) <.001
PRU, Peripheral resistance units.
Figures in bold indicate statistical significance.graft outcome are shown in Table III. Overall, grafts thatfailed by six weeks had significantly lower flows and higher
resistance measurements, both before and after administra-
tion of papaverine, than grafts that remained patent. In
order to assess whether these measurements could be of use
in predicting individual graft failure, receiver operating
characteristic (ROC) curves were plotted. The areas under
the curves (sd) for pre-papaverine flow and resistance and
post-papaverine flow and resistance were 0.568 (0.048),
0.573 (0.048), 0.632 (0.045), and 0.603 (0.045), respec-
tively, indicating that these measurements have a poor
discriminating ability to identify the likelihood of an indi-
vidual graft failing.
Graft surveillance. Of the 346 vein grafts that re-
-AK pop Fem-BK pop Fem-distal P
(38) 161 (34) 131 (28)
(10.8) 71.1 (10.4) 73.9 (11.0) .003*
20:56 116:45 89:42 .675
†
(105.0) 88.2 (106.2) 52.1 (87.1) .003*
(43) 25 (16) 10 (8) <.001
†
(22) 41 (25) 51 (39)
(32) 46 (29) 62 (47)
0 33 (20) 1 (1)
(3) 16 (10) 7 (5)
(85) 134 (83) 111 (85) .001
†
(11) 5 (4) 7 (5)
(4) 22 (14) 13 (10)
85% 81% 77% .142
¶
87% 82% 77% .139
¶
63% 50% 43% <.001
¶
78% 70% 58% <.001
¶
(5) 4 (3) 8 (6) .306
†
(11) 12 (8) 30 (23) <.001
†
(15) 22 (14) 39 (30) <.001
†
(7) 19 (12) 26 (20) .003
†
moro-above knee popliteal graft; Fem-BK pop, femoro-below knee popliteal
t claudication; M, male; sd, standard deviation.
ate statistical significance.
Table III. OpDop calculated flow and resistance values
for grafts compared to patency status at six weeks
Graft status at six weeks Patent Failed P
Flow (mLs/min)
Pre-papaverine 150.6 (82.9) 130.5 (63.9) .009*
Post-papaverine 243.1 (101.2) 209.1 (96.9) <.001*
Resistance (PRU)
Pre-papaverine 0.57 (0.26) 0.67 (0.35) .004*
Post-papaverine 0.34 (0.15) 0.40 (0.23) .016*
PRU, Peripheral resistance units.
Figures in bold indicate statistical significance.


















d indicmained patent at six weeks, 254 (73.4%) were entered into
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were followed up clinically. Both groups were well matched
for baseline demographic and peri-operative details (Table
IV). In the surveillance group, 84 (33%) grafts underwent
additional therapeutic intervention (percutaneous balloon
angioplasty [72], surgical revision [12; patch angioplasty
(9), jump graft (3)] after a mean (sd) period of 34.3 (48.2)
weeks. All surgical revisions were preceded by an attempt
by percutaneous balloon angioplasty. This compares with
only four (4%) subjects in the clinical follow-up group
undergoing additional intervention (all percutaneous bal-
loon angioplasty) after a mean (sd) of 53.4 (35.4) weeks.
There was no statistical difference in primary 18-month
patency rates between grafts undergoing surveillance and
those undergoing clinical follow up (55% vs. 76%; P 
.205, log rank test). However, primary-assisted 18-month
patency rates were significantly higher in subjects undergo-
ing duplex surveillance (83% vs. 77%; P  .019, log rank
test) (Fig 1). There were a higher proportion of major
amputations (amputation of the leg above the level of the
ankle) in the clinical follow-up group (12% vs. 4%; P 
.005, Chi-squared) and this remained statistically signifi-
cant when amputations with patent grafts were excluded
(7% vs. 2%; P  .013, Chi-squared). All amputations oc-
Table IV. Demographic details of subjects in the
surveillance and clinical follow-up groups
Surveillance Clinical P
Number 254 92
Mean age (sd) years 70.6 (10.3) 70.6 (10.8) .990*
Sex M:F 181:73 68:24 0.627
†
Mean follow-up (sd) weeks 106.4 (93.9) 89.7 (128.8) 0.189*
Indication for surgery
IC 73 (29) 20 (22) .155
†
CLI – rest pain 70 (28) 24 (26)
CLI – tissue loss 74 (29) 39 (42)
Popliteal aneurysm 26 (10) 5 (5)
ALI 11 (4) 4 (4)
Distal anastamosis
Above knee popliteal 106 (42) 29 (32) .209
†
Below knee popliteal 89 (35) 36 (39)
Tibial vessel 59 (23) 27 (29)
Conduit
Reversed GSV 205 (81) 85 (92) .057
†
In situ GSV 25 (10) 2 (2)
Cephalic vein 24 (9) 5 (5)
Primary three-year patency 52% 60% .133
¶
Primary-assisted three-year
patency 80% 70% .042
¶
Major amputation
All cases 9 (4) 11 (12) .005
†
With occluded graft 5 (2) 6 (7) .013
†
ALI, Acute limb ischaemia; CLI, critical limb ischaemia; F, female; GSV,
great saphenous vein; IC, intermittent claudication; M, male; sd, standard
deviation.




¶Log rank test.curred in subjects with either acute or critical limb isch-aemia. No subject undergoing bypass surgery for intermit-
tent claudication or popliteal aneurysm underwent a major
amputation.
DISCUSSION
The 18-month patency rates reported in this series
(53% primary and 70% primary-assisted) appear slightly
lower than reported in other series. There are a number of
explanations for this. The patency rates reported are pooled
data for all types of graft performed and for all indications
and degree of urgency. The primary patency rates may
appear low due to the high use of duplex surveillance in this
study and the strict criteria used for graft failure (70%
stenosis). Other series with clinical follow-up will inevitably
report higher primary patency rates (as was seen in the
clinical follow-up group of our study). Another major
factor may be our department’s strict policy on using vein as
a conduit whenever possible. In a recent audit, only 3% of
our infra-inguinal grafts used a prosthetic conduit (1.6% as
a composite). Our aggressive policy of using vein as a
conduit will undoubtedly mean that some conduits are
poorer quality than others and will lead to a reduction in
overall patency rates for the group as a whole. We firmly
believe that this approach is the correct one, given the
significantly poorer outcome observed with prosthetic
grafts.
Quality control assessment, therefore, following com-
pletion of venous bypass grafts, is an important component
of infra-inguinal bypass surgery, being able to detect tech-
nical errors that, if left uncorrected, may result in early graft
failure. Even in the absence of technical errors, quality
control assessment has the potential to identify grafts
deemed to be at ‘high-risk’ that may benefit from aggres-
sive postoperative medical management such as formal
anticoagulation, the use of Dextrans, or entry into a high-
intensity surveillance program.
A number of quality control methods have been assessed,
including completion angiography,7 intraoperative duplex
scanning,15 angioscopy,11 and Doppler flow assessment.16
Completion angiography has been considered the gold
standard in graft quality control assessment as it gives good
visualisation of the graft, anastamoses, and run-off vessels
and helps to exclude technical errors with the anastamoses
and the graft.7 Despite this, angiography only offers a 2D
image, and up to 25% of grafts with a normal completion
angiogram have haemodynamic abnormalities detected by
an early duplex scan.17 Furthermore, completion angiog-
raphy has not been shown to alter short- or intermediate-
term graft patency.10
Angioscopy had its proponents in the 1990s8 and
proved more useful in assessing the quality of the venous
conduit than angiography but has fallen out of favor,
largely due to the inability to adequately assess the distal
vasculature.11
Intraoperative Duplex assessment of grafts appears to
be the most useful modality to assess graft function and may
have the ability to predict future stenotic development and
graft failure.9,18,19 Duplex assessment, however, is user
JOURNAL OF VASCULAR SURGERY
June 20091456 Hobbs et aldependent and subject to wide interoperator variability and
thus there may be advantages to using a device capable of
standardizing measurements graft flow and resistance, such
as the OpDop. A number of studies have assessed comple-
tion Doppler spectral analysis of graft flow and resistance,
but these have generated conflicting results. Beard et al
were one of the first to assess this and found that, although
graft flow was of little value in predicting graft outcome,
Fig 1. Kaplan Meier plots for (a) primary and (b) prim
(green) or clinical follow-up (blue).
Fig 1a. Numbers at risk (events)
Months 0 3 6
Clinical 92 (9) 67 (15) 53 (16)
Duplex 254 (30) 220 (62) 180 (85)
Fig 1b. Numbers at risk (events)
Months 0 3 6
Clinical 92 (9) 67 (15) 53 (15)
Duplex 254 (13) 237 (31) 208 (35)high post-papaverine peripheral resistance correlated wellwith one-month patency.12 While these findings have been
confirmed in several later studies,9,20 there is further con-
flicting data published demonstrating no relationship be-
tween resistance values and early graft outcome.16,21
In this present study, which contains a significantly
larger number of cases than previous studies, we identified
a significant relationship between low graft flow and high
graft resistance with early (six-week) graft failure. Despite
sisted patency for grafts undergoing duplex surveillance
9 12 15 18
48 (16) 54 (17) 37 (17) 34
53 (96) 136 (102) 118 (108) 109
9 12 15 18
49 (15) 55 (16) 38 (16) 35
97 (39) 187 (42) 178 (42) 164ary-as
1
1this correlation, our ROC analysis failed to identify cut-off
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high risk of short-term failure. We therefore found that, for
individual cases, the Doppler flow measurements were un-
able to predict the short-term outcome of grafts. The
identification of a simple test to predict the outcome of
bypass grafts would be extremely welcome and would allow
focused surveillance of those grafts most at risk. This study,
however, provides further evidence that while intraopera-
tive graft flow and resistance measurements have an associ-
ation with graft outcome, no single measure has sufficient
ability to risk stratify individual grafts. The reasons for this
disappointing finding are likely to be complex and multi-
factorial. Either these measurements are unable to identify
grafts that are not technically satisfactory or technically
sound grafts undergo early failure secondary to other fac-
tors in the post-operative period (for example, systemic
hypotension, coagulopathy, or external compression). As a
result, we have discontinued the use of the OpDop as a
quality control assessment in our unit.
This study also assessed the value of duplex surveillance
on mid-term patency of venous bypass grafts. While this is
not a randomized controlled trial, there were no significant
changes to operative and clinical practice over the study
period, and, as a result, the two follow-up groups are
comparable. In this present study of 468 vein grafts with an
average follow-up of 18 months, we have demonstrated a
significant benefit to vein graft surveillance compared to
clinical follow-up both in terms of graft patency (80% vs.
70%; P  .042) and amputation rates (4% vs. 12%; P 
.005).
Vein graft surveillance has been a topic that has been
the subject of much debate over the years and a number of
randomized trials have provided conflicting views on the
benefit of graft surveillance programs. Lundell et al22 as-
sessed the value of duplex surveillance versus clinical
follow-up in 106 vein grafts in a randomized controlled
trial and found superior patency rates in grafts followed up
by duplex assessment (primary assisted patency 78% vs 53%;
P  .05). No significant benefit, however, was found in
terms of limb salvage rates. A further randomized con-
trolled trial, Ihlberg et al,23 failed to show any beneficial
effect of duplex scanning on graft patency or limb salvage in
a surveillance program of 185 vein grafts. This study,
however, has been criticized for having numerous radiolo-
gists performing the surveillance duplex scans (n  22, of
which 39% were trainees) and for only obtaining 60%
follow-up in the duplex arm. In a follow-up study by the
same authors, subjects who adhered to trial protocol (90
subjects clinical follow-up, 57 subjects duplex surveillance)
were analyzed, and no difference in graft patency rates was
found, despite a higher graft revision rate in the duplex
group.24
The largest and most recent randomized study to date
is that by Davies et al25 and was designed to settle the
matter. This trial identified no benefit to duplex surveil-
lance over clinical surveillance in terms of patency rates or
limb salvage rates. They also concluded that there were no
differences in health-related quality of life and that the costsof a duplex surveillance program were greater than clinical
surveillance. This randomized clinical trial (RCT) had orig-
inally planned to recruit 1200 subjects but, due to difficulty
in recruitment, only 594 subjects were recruited from 29
centers in the UK and Europe. This equates to an average of
20 subjects per center, with 10 randomized to duplex
surveillance. The small number of patients per center means
that the trial could be subject to variations in the results of
treatments in the different centers – for example, some
centers may have a high complication rate from graft an-
gioplasty and skew the patency rates of the surveillance
group. Thus, while multicenter randomized controlled tri-
als may offer the best evidence for guiding generalized
practice, an equivocal finding does not mean that duplex
surveillance cannot be successful in individual centers with
a well run program and a low complication rate from
intervention.
CONCLUSION
This present study has demonstrated no significant
advantage of intraoperative Doppler wave analysis of com-
pleted infra-inguinal vein grafts on short term graft pa-
tency. We have, however, demonstrated that, in our hands,
a well conducted vein graft surveillance program results in
superior mid-term graft patency rates, translating into im-
proved limb salvage rates.
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